KEY FEATURES
| Full Name | Apolipoprotein A1 |
|---|---|
| Synonym | APOA1, Apo-A1 |
| Assay Type | Sandwich |
| Reactivity | Monkey |
| Range | 1.56-100ng/mL |
| Sensitivity | 0.94ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Monkey ApoA1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Monkey ApoA1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Monkey ApoA1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Monkey ApoA1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Monkey ApoA1. You can calculate the concentration of Monkey ApoA1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Monkey ApoA1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 4.69 | 14.42 | 42.45 | 4.39 | 13.71 | 41.62 |
| Standard deviation | 0.3 | 0.72 | 1.64 | 0.24 | 0.59 | 1.99 |
| CV(%) | 6.47 | 4.99 | 3.86 | 5.51 | 4.27 | 4.77 |
RECOVERY
The recovery of Monkey ApoA1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 86-100 | 92 |
| EDTA plasma (n=8) | 87-101 | 93 |
| Cell culture media (n=8) | 90-104 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Monkey ApoA1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with APOA1 ELISA Kits
| APOB ELISA Kit | publications with APOA1 and APOB |
| ABCA1 ELISA Kit | publications with APOA1 and ABCA1 |
| APOC3 ELISA Kit | publications with APOA1 and APOC3 |
| CETP ELISA Kit | publications with APOA1 and CETP |
| LCAT ELISA Kit | publications with APOA1 and LCAT |
| APOA2 ELISA Kit | publications with APOA1 and APOA2 |
| ALB ELISA Kit | publications with APOA1 and ALB |
| TTR ELISA Kit | publications with APOA1 and TTR |
| MTTP ELISA Kit | publications with APOA1 and MTTP |
Pathways associated with APOA1 ELISA Kit
| ABC-family Proteins Mediated Transport Pathway | ABC-family Proteins Mediated Transport Pathway |
| ABCA Transporters In Lipid Homeostasis Pathway | ABCA Transporters In Lipid Homeostasis Pathway |
| African Trypanosomiasis Pathway | African Trypanosomiasis Pathway |
| Amyloids Pathway | Amyloids Pathway |
| Binding And Uptake Of Ligands By Scavenger Receptors Pathway | Binding And Uptake Of Ligands By Scavenger Receptors Pathway |
| Chylomicron-mediated Lipid Transport Pathway | Chylomicron-mediated Lipid Transport Pathway |
| Disease Pathway | Disease Pathway |
| Diseases Associated With Visual Transduction Pathway | Diseases Associated With Visual Transduction Pathway |
| FOXA2 And FOXA3 Transcription Factor Networks Pathway | FOXA2 And FOXA3 Transcription Factor Networks Pathway |
Diseases associated with APOA1 ELISA Kit
| Cardiovascular Diseases | publications with APOA1 and Cardiovascular Diseases |
| Atherosclerosis | publications with APOA1 and Atherosclerosis |
| Dyslipidemias | publications with APOA1 and Dyslipidemias |
| Heart Diseases | publications with APOA1 and Heart Diseases |
| Hyperlipidemias | publications with APOA1 and Hyperlipidemias |
| Insulin Resistance | publications with APOA1 and Insulin Resistance |
| Inflammation | publications with APOA1 and Inflammation |
| Hypertension | publications with APOA1 and Hypertension |
| Hypercholesterolemia | publications with APOA1 and Hypercholesterolemia |
| Hypertriglyceridemia | publications with APOA1 and Hypertriglyceridemia |
Organs/Tissues associated with APOA1 ELISA Kit
| Blood | publications with APOA1 and Blood |
| Liver | publications with APOA1 and Liver |
| Heart | publications with APOA1 and Heart |
| Muscle | publications with APOA1 and Muscle |
| Brain | publications with APOA1 and Brain |
| Ovary | publications with APOA1 and Ovary |
| Lung | publications with APOA1 and Lung |
| Intestine | publications with APOA1 and Intestine |
| Pancreas | publications with APOA1 and Pancreas |
| Embryonic Tissue | publications with APOA1 and Embryonic Tissue |